AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20555272 — intervention group
Group type: EXPERIMENTAL
Intervention: Uniaxial unstable surface balance training on a rocker board (RB)
Number of subjects: 36
Study 20555272 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiaxial unstable surface balance training on a dynadisc (DD)
Number of subjects: 36
Study 20555272 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment groups (DD and RB)
Number of subjects: 36
Study 20555272 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 36
Study 20555272 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups combined (CON + DD + RB)
Number of subjects: 36
Study 17585663 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-through-point electroacupuncture (EA)
Number of subjects: 108
Study 17585663 — intervention group
Group type: COMPARATOR
Intervention: Non point-through-point group
Number of subjects: 108
Study 17585663 — intervention group
Group type: COMPARATOR
Intervention: Western medicine group
Number of subjects: 108
Study 15065482 — intervention group
Group type: EXPERIMENTAL
Intervention: Component parts of pulmonary rehabilitation
Number of subjects: 0
Study 11811810 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized music
Number of subjects: 4
Study 11811810 — intervention group
Group type: COMPARATOR
Intervention: Classical music
Number of subjects: 4
Study 11811810 — intervention group
Group type: COMPARATOR
Intervention: Control period without music
Number of subjects: 4
Study 9625841 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic chemotherapy in NSCLC (14 patients)
Number of subjects: 23
Study 9625841 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic chemotherapy in SCLC (9 patients)
Number of subjects: 23
Study 7939505 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracotomy in cirrhotic patients
Number of subjects: 11
Study 7939505 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal liver function)
Number of subjects: 11
Study 7939505 — intervention group
Group type: EXPERIMENTAL
Intervention: Management of significant pleural effusions in cirrhotic patients
Number of subjects: 11
Study 3286783 — intervention group
Group type: EXPERIMENTAL
Intervention: Norfloxacin (400 mg) every 12 hours for 28 days
Number of subjects: 24
Study 3286783 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 28553835 — intervention group
Group type: EXPERIMENTAL
Intervention: Baclofen
Number of subjects: 12
Study 28553835 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivastigmine
Number of subjects: 12
Study 28553835 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextromethorphan
Number of subjects: 12
Study 28553835 — intervention group
Group type: EXPERIMENTAL
Intervention: L-DOPA
Number of subjects: 12
Study 28553835 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 27429397 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 other person present during simulation
Number of subjects: 70
Study 27429397 — intervention group
Group type: COMPARATOR
Intervention: 3 other people present during simulation
Number of subjects: 70
Study 24650839 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based dietitian-led (WD) team care intervention
Number of subjects: 101
Study 24650839 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 101
Study 22940254 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbal medicines only (57 patients)
Number of subjects: 313
Study 22940254 — intervention group
Group type: COMPARATOR
Intervention: Herbal and conventional medicines concurrently (256 patients)
Number of subjects: 313
Study 20729255 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic preparation (Lactobacillus helveticus R0052, Bifidobacterium infantis R0033, Bifidobacterium bifidum R0071, and fructooligosaccharide)
Number of subjects: 135
Study 20729255 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study 20729255 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic preparation
Number of subjects: 135
Study 18685795 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolterodine ER
Number of subjects: 201
Study 18685795 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 201
Study 15671472 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-session intervention
Number of subjects: 0
Study 15671472 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0
Study 15576257 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month, 3 times per week, leader-led walking group activity (n = 28)
Number of subjects: 582
Study 15576257 — intervention group
Group type: COMPARATOR
Intervention: Information-only control group (n = 28)
Number of subjects: 582
Study 11719721 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone follow-up discussions
Number of subjects: 185
Study 11719721 — intervention group
Group type: COMPARATOR
Intervention: Appointment follow-ups
Number of subjects: 185
Study 9594263 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (group A)
Number of subjects: 1106
Study 9594263 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (group E)
Number of subjects: 1106
Study 9594263 — intervention group
Group type: COMPARATOR
Intervention: Control (group C)
Number of subjects: 1106
Study 9594263 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol and Enalapril
Number of subjects: 1106
Study 8201563 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirated Viscoat (30 eyes)
Number of subjects: 55
Study 8201563 — intervention group
Group type: EXPERIMENTAL
Intervention: Retained Viscoat (30 eyes)
Number of subjects: 55
Study 2852948 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy (cisplatin and etoposide)
Number of subjects: 101
Study 2852948 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy of the thorax
Number of subjects: 101
Study 31880479 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuation of treatment with 36 or 54 mg extended release methylphenidate for 7 weeks
Number of subjects: 94
Study 31880479 — intervention group
Group type: COMPARATOR
Intervention: Gradual withdrawal over 3 to 4 weeks placebo
Number of subjects: 94
Study 31567676 — intervention group
Group type: EXPERIMENTAL
Intervention: Pectoralis major tendon transfer (PMT)
Number of subjects: 28
Study 28627070 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrolysed wheat flour (10 g of gluten/d for 3 days)
Number of subjects: 20
Study 28627070 — intervention group
Group type: COMPARATOR
Intervention: Natural wheat flour (10 g of gluten/d for 3 days)
Number of subjects: 20
Study 26545731 — intervention group
Group type: EXPERIMENTAL
Intervention: Entonox
Number of subjects: 123
Study 26545731 — intervention group
Group type: EXPERIMENTAL
Intervention: Play therapy
Number of subjects: 123
Study 26545731 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Entonox and play therapy
Number of subjects: 123
Study 26545731 — intervention group
Group type: COMPARATOR
Intervention: Existing standard interventions (Control)
Number of subjects: 123
Study 23404916 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 149
Study 23404916 — intervention group
Group type: COMPARATOR
Intervention: Control (cuff deflated)
Number of subjects: 149
Study 21216860 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated bio-behavioral feedback (levels 1-2-3 or 2-3-1)
Number of subjects: 120
Study 17435692 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg intravitreal triamcinolone acetonide injection
Number of subjects: 38
Study 17435692 — intervention group
Group type: COMPARATOR
Intervention: Control (fellow eyes)
Number of subjects: 38
Study 16442667 — intervention group
Group type: EXPERIMENTAL
Intervention: Gain-framed nutrition message (positive benefits of eating apples)
Number of subjects: 50
Study 16442667 — intervention group
Group type: EXPERIMENTAL
Intervention: Loss-framed nutrition message (negative consequences of not eating apples)
Number of subjects: 50
Study 16442667 — intervention group
Group type: COMPARATOR
Intervention: Control scene (children playing a game)
Number of subjects: 50
Study 14518703 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-a-day regimen (EFV+ddl+3TC)
Number of subjects: 102
Study 14518703 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-a-day low-pill burden regimen (EFV+Combivir)
Number of subjects: 102
Study 14518703 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-a-day high-pill burden regimen (NFV+Combivir)
Number of subjects: 102
Study 10606833 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled rac-salbutamol (1200 microg) with oral charcoal
Number of subjects: 15
Study 10606833 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous rac-salbutamol (500 microg)
Number of subjects: 15
Study 9083592 — intervention group
Group type: EXPERIMENTAL
Intervention: Didactic lecture format
Number of subjects: 57
Study 9083592 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic algorithm presentation
Number of subjects: 57
Study 9083592 — intervention group
Group type: EXPERIMENTAL
Intervention: Color slide photographic demonstration
Number of subjects: 57
Study 9083592 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedside teaching rounds
Number of subjects: 57
Study 9083592 — intervention group
Group type: EXPERIMENTAL
Intervention: Meet-the-professor sessions
Number of subjects: 57
Study 9083592 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall instructional methods
Number of subjects: 57
Study 8248391 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep deprivation
Number of subjects: 0
Study 8248391 — intervention group
Group type: COMPARATOR
Intervention: Lunch consumption
Number of subjects: 0
Study 8248391 — intervention group
Group type: EXPERIMENTAL
Intervention: Trait anxiety
Number of subjects: 0
Study 8248391 — intervention group
Group type: EXPERIMENTAL
Intervention: Extraversion vs. Introversion in sleep-deprived subjects
Number of subjects: 0
Study 2868579 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. famotidine 10 mg every 6-12 hours for maximally seven days
Number of subjects: 20
Study 2868579 — intervention group
Group type: COMPARATOR
Intervention: i.v. ranitidine every 6-12 hours for maximally seven days
Number of subjects: 20
Study 31146740 — intervention group
Group type: EXPERIMENTAL
Intervention: MCT oil supplement (9% metabolic energy based calculated)
Number of subjects: 36
Study 31146740 — intervention group
Group type: COMPARATOR
Intervention: Control dietary supplement (DS)
Number of subjects: 36
Study 28077059 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-hour course on the Danish healthcare system
Number of subjects: 1158
Study 28077059 — intervention group
Group type: EXPERIMENTAL
Intervention: Written information on the Danish healthcare system
Number of subjects: 1158
Study 28077059 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1158
Study 26455674 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagery Rehearsal Therapy (IRT) consisting of 6 individual sessions
Number of subjects: 90
Study 26455674 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagery Rehearsal Therapy (IRT)
Number of subjects: 90
Study 26455674 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 90
Study 23876862 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse childhood experiences (ACE)
Number of subjects: 180
Study 21393398 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated obstructive hypopnea (inspiration through threshold load)
Number of subjects: 20
Study 21393398 — intervention group
Group type: EXPERIMENTAL
Intervention: Müller maneuver (simulated obstructive apnea)
Number of subjects: 20
Study 21393398 — intervention group
Group type: EXPERIMENTAL
Intervention: End‐expiratory central apnea
Number of subjects: 20
Study 21393398 — intervention group
Group type: EXPERIMENTAL
Intervention: Release of threshold load inspiration
Number of subjects: 20
Study 21393398 — intervention group
Group type: EXPERIMENTAL
Intervention: Release of Müller maneuver
Number of subjects: 20
Study 21393398 — intervention group
Group type: EXPERIMENTAL
Intervention: Release of end‐expiratory central apnea
Number of subjects: 20
Study 18982437 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-week oral anticoagulation therapy (OACs) before heparin bridging
Number of subjects: 188
Study 18982437 — intervention group
Group type: COMPARATOR
Intervention: No prior oral anticoagulation therapy (N-OACs)
Number of subjects: 188
Study 17237480 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemodiafiltration with online regeneration of ultrafiltrate (HFR)
Number of subjects: 14
Study 17237480 — intervention group
Group type: COMPARATOR
Intervention: Low-flux bicarbonate dialysis (HD)
Number of subjects: 14
Study 14971670 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenaline and saline infiltration (2.5 mg of 1:1000 adrenaline diluted in 500 mL of normal saline)
Number of subjects: 115
Study 14971670 — intervention group
Group type: COMPARATOR
Intervention: Tourniquet and postoperative drain
Number of subjects: 115
Study 11167277 — intervention group
Group type: EXPERIMENTAL
Intervention: Latanoprost once daily
Number of subjects: 35
Study 11167277 — intervention group
Group type: COMPARATOR
Intervention: Timolol plus dorzolamide twice daily
Number of subjects: 35
Study 9693996 — intervention group
Group type: EXPERIMENTAL
Intervention: Panic disorder patients
Number of subjects: 53
Study 9693996 — intervention group
Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 53
Study 9693996 — intervention group
Group type: EXPERIMENTAL
Intervention: Panic disorder patients and normal controls
Number of subjects: 53
Study 7872717 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 81
Study 3061449 — intervention group
Group type: EXPERIMENTAL
Intervention: Argon laser photocoagulation
Number of subjects: 0
Study 31443939 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentamicin-coated intramedullary interlocking nail
Number of subjects: 28
Study 31443939 — intervention group
Group type: COMPARATOR
Intervention: Regular intramedullary interlocking nail
Number of subjects: 28
Study 28711629 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard high-level disinfection (sHLD)
Number of subjects: 541
Study 28711629 — intervention group
Group type: EXPERIMENTAL
Intervention: Double high-level disinfection (dHLD)
Number of subjects: 541
Study 28711629 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard high-level disinfection followed by ethylene oxide gas sterilization (HLD/ETO)
Number of subjects: 541
Study 28711629 — intervention group
Group type: COMPARATOR
Intervention: Pre-procedure rectal swabs
Number of subjects: 541
Study 28711629 — intervention group
Group type: COMPARATOR
Intervention: Duodenal aspirates
Number of subjects: 541
Study 25474338 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral + Unilateral Plyometric Training (B + UG)
Number of subjects: 54
Study 25474338 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral Plyometric Training (UG)
Number of subjects: 54
Study 25474338 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral Plyometric Training (BG)
Number of subjects: 54
Study 25474338 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 54
Study 23921338 — intervention group
Group type: EXPERIMENTAL
Intervention: PRP-augmented treatment
Number of subjects: 48
Study 23921338 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 48
Study 19217236 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal tube suction-device (LTS-D)
Number of subjects: 150
Study 19217236 — intervention group
Group type: COMPARATOR
Intervention: Endotracheal intubation (ET)
Number of subjects: 150
Study 19217236 — intervention group
Group type: COMPARATOR
Intervention: Bag-mask-valve ventilation (BMV)
Number of subjects: 150
Study 19454547 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprepitant (NK1 receptor antagonist)
Number of subjects: 0
Study 19454547 — intervention group
Group type: EXPERIMENTAL
Intervention: Other NK1 receptor antagonists (under investigation)
Number of subjects: 0
Study 17096096 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral stimulation in the subthalamic nucleus (STN)
Number of subjects: 35
Study 17096096 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-operated PD patients)
Number of subjects: 35
Study 15050851 — intervention group
Group type: EXPERIMENTAL
Intervention: Snoezelen intervention for caregivers
Number of subjects: 6
Study 15058213 — intervention group
Group type: EXPERIMENTAL
Intervention: Wenshen Xiezhuo Decoction (WSXZD) plus low-protein diets, controlling hypertension, and symptomatic treatment
Number of subjects: 60
Study 15058213 — intervention group
Group type: COMPARATOR
Intervention: Low-protein diets, controlling hypertension, and symptomatic treatment
Number of subjects: 60
Study 10194144 — intervention group
Group type: EXPERIMENTAL
Intervention: AHR strategy
Number of subjects: 75
Study 10194144 — intervention group
Group type: COMPARATOR
Intervention: reference strategy
Number of subjects: 75
Study 7538837 — intervention group
Group type: EXPERIMENTAL
Intervention: Amylyte ORS
Number of subjects: 198
Study 2328561 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine daily administration (8 mg)
Number of subjects: 19
Study 2328561 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine alternate-day administration
Number of subjects: 19
Study 2328561 — intervention group
Group type: COMPARATOR
Intervention: Placebo administration
Number of subjects: 19
Study 38821 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam 5 mg
Number of subjects: 6
Study 38821 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam 10 mg
Number of subjects: 6
Study 38821 — intervention group
Group type: EXPERIMENTAL
Intervention: Temazepam 30 mg
Number of subjects: 6
Study 38821 — intervention group
Group type: EXPERIMENTAL
Intervention: Temazepam 20 mg
Number of subjects: 6
Study 38821 — intervention group
Group type: EXPERIMENTAL
Intervention: Temazepam 10 mg
Number of subjects: 6
Study 31281958 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower Hb-threshold for RBC transfusion
Number of subjects: 0
Study 31281958 — intervention group
Group type: COMPARATOR
Intervention: Higher Hb-threshold for RBC transfusion
Number of subjects: 0
Study 28042054 — intervention group
Group type: EXPERIMENTAL
Intervention: Tight glycemic control with a blood glucose target range of 80-110 mg/dL (4.4-6.1 mmol/L)
Number of subjects: 1414
Study 28042054 — intervention group
Group type: COMPARATOR
Intervention: Standard glycemic control with a blood glucose target range of 150-180 mg/dL (8.3-10.0 mmol/L)
Number of subjects: 1414
Study 26747421 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic milk (150 mL of milk supplemented with Lactobacillus rhamnosus SP1 at 10(7) CFU/mL)
Number of subjects: 261
Study 26747421 — intervention group
Group type: COMPARATOR
Intervention: Standard milk
Number of subjects: 261
Study 26747421 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic milk
Number of subjects: 261
Study 24256479 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy with self-hypnosis (7 sessions)
Number of subjects: 49
Study 24256479 — intervention group
Group type: COMPARATOR
Intervention: Cognitive-behavioral therapy without self-hypnosis (11 sessions)
Number of subjects: 49
Study 24256479 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (hypnosis and no-hypnosis)
Number of subjects: 49
Study 22137119 — intervention group
Group type: EXPERIMENTAL
Intervention: Pramipexole
Number of subjects: 305
Study 22137119 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 305
Study 20661199 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway (LMA-C)
Number of subjects: 40
Study 20661199 — intervention group
Group type: COMPARATOR
Intervention: Endotracheal Tube (ETT)
Number of subjects: 40
Study 17768103 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma derived C1‐INH
Number of subjects: 0
Study 17768103 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzyme inhibitor Dx‐88
Number of subjects: 0
Study 17768103 — intervention group
Group type: EXPERIMENTAL
Intervention: Receptor antagonist Icatibant
Number of subjects: 0
Study 17768103 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant form of human C1‐INH
Number of subjects: 0
Study 15831784 — intervention group
Group type: EXPERIMENTAL
Intervention: Azacitidine administered as a single 75‐mg/m(2) SC dose
Number of subjects: 6
Study 15831784 — intervention group
Group type: COMPARATOR
Intervention: Azacitidine administered as a single 75‐mg/m(2) IV infusion dose over 10 minutes
Number of subjects: 6
Study 11979401 — intervention group
Group type: EXPERIMENTAL
Intervention: Margarine with sterol esters (MSE; 1.92 g/d)
Number of subjects: 15
Study 11979401 — intervention group
Group type: EXPERIMENTAL
Intervention: Margarine with stanol esters (MSA; 1.76 g/d)
Number of subjects: 15
Study 11979401 — intervention group
Group type: COMPARATOR
Intervention: Margarine (M)
Number of subjects: 15
Study 9882991 — intervention group
Group type: EXPERIMENTAL
Intervention: Rokitamycin, 400 mg tablet every 12 hours for 14 days
Number of subjects: 30
Study 9882991 — intervention group
Group type: COMPARATOR
Intervention: Josamycin, 500 mg tablet every 8 hours for 14 days
Number of subjects: 30
Study 8564679 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (3.4 +/- 1.3 mg)
Number of subjects: 211
Study 8564679 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 211
Study 31089262 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep (10% more sleep)
Number of subjects: 690
Study 31089262 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-to-vigorous physical activity (MVPA) (10% more MVPA)
Number of subjects: 690
Study 31089262 — intervention group
Group type: EXPERIMENTAL
Intervention: Compositional time use
Number of subjects: 690
Study 30002871 — intervention group
Group type: EXPERIMENTAL
Intervention: Effective family planning (EFP) methods (injectable, oral, intra‐uterine contraceptive device, or Norplant)
Number of subjects: 0
Study 27861326 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic resonance-guided laser-induced thermal therapy (MRgLITT)
Number of subjects: 25
Study 26694646 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid-based nutrient supplements (LNS)
Number of subjects: 1391
Study 26694646 — intervention group
Group type: COMPARATOR
Intervention: Multiple micronutrient (MMN) supplements
Number of subjects: 1391
Study 26694646 — intervention group
Group type: COMPARATOR
Intervention: Iron-folic acid (IFA) supplements
Number of subjects: 1391